Investors / i&i Bio
i&i Bio
Venture capital
i&i Bio is a venture capital fund focused exclusively on life science ventures, embedded in the ecosystem around the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. It backs early-stage startups addressing unmet medical needs and supports them from business creation through growth funding.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechdrug discoverymedtechdiagnosticsai
Your fit with i&i Bio
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsi&i Bio lists 22 checked portfolio companies on its own site and is named in 6 funding rounds, 1 of them as lead. Its most frequent entry is Seed, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (74%), Fintech (13%) and E-commerce & Marketplaces (4%). 35% of its companies are based in Czech Republic. It invests most often alongside Tensor Ventures, UKI2S and Amino Collective.
Counts come from funding rounds that name i&i Bio, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not i&i Bio's whole history. Rounds on record name 5 companies; its own site lists 22. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 60% |
| Series A | 40% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 1 | 1 |
| '25 | 2 | 0 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 55th | 22 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 76th | 60% of entries at pre-seed or seed |
| Evidence | 93th | 23% of companies confirmed by a round |
| Sector focus | 92th | 74% in its largest sector |
| Reach | 91th | 8 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Tensor Ventures | 2 |
| UKI2S | 2 |
| Amino Collective | 1 |
| Bayern Kapital | 1 |
| BiomedVC | 1 |
| Brandenburg Kapital | 1 |
| Creative Destruction Lab | 1 |
| Credo Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers22100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 74% | 15% |
| Fintech | 13% | 12% |
| E-commerce & Marketplaces | 4% | 6% |
| Education | 4% | 7% |
| Industrial & Manufacturing | 4% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare i&i Bio head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with i&i Bio| Date | Company | Stage |
|---|---|---|
| 27 Mar 2026 | Seed | |
| 16 Mar 2026 | Seed | |
| 3 Mar 2026 | Series A | |
| 17 Dec 2025 | Series A | |
| 17 Nov 2025 | Series A | |
| 22 May 2024 | Seed Led |
Round details for i&i Bio
Amounts, full round histories and every co-investor in i&i Bio's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
22 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Antiverse discovers biologics for challenging targets in medicine using generative AI | Healthcare & Biotech | Mar 2026Series A | Page + round | |
| May 2024Seed · 2 rounds | Page + round | |||
| CasInvent Pharma develops new therapeutic options for the treatment of resistant tumors | Healthcare & Biotech | Portfolio page | ||
| The company provides banking and investment services. | FintechFintech | Portfolio page | ||
| The company realizes the transfer of scientific knowledge into everyday life and ensures technological transfer for Charles University and other institutions. | EducationIndustrial & Manufacturing | Portfolio page | ||
| Delta Life Science provides label-free biosensing products and services for biomolecular research and development | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company provides financing to businesses and infrastructure projects in Europe. | FintechE-commerce & Marketplaces | Portfolio page | ||
| Enzyre develops and provides near patient diagnostics focused on blood coagulation | Healthcare & Biotech | Portfolio page | ||
| Heartbeat Bio generates human heart chamber models for cardiac drug discovery and disease modeling | Healthcare & Biotech | Portfolio page | ||
| The company helps groundbreaking biotech ideas leap from lab to market by providing support and funding to start-ups in the early stages of their development | Healthcare & Biotech | Portfolio page | ||
| IOCB Tech identifies scientifically robust, de-risked projects from Europe's leading chemistry institute, IOCB Prague, and scales them for the global market. | Healthcare & Biotech | Portfolio page | ||
| iQure Pharma is a clinical-stage biotech company developing first-in-class astrocyte-targeted therapeutics designed to restore glutamate balance in CNS disorders. | Healthcare & Biotech | Portfolio page | ||
| KyDo Therapeutics is a preclinical-stage biotechnology company developing novel covalent-allosteric small-molecule inhibitors for the treatment of genetically defined cancers | Healthcare & Biotech | Portfolio page | ||
| LAM-X designs materials that protect health, purify water, and enable discovery | Healthcare & Biotech | Portfolio page | ||
| Nanoligent designs new precision medicines that selectively target the cells affected by disease | Healthcare & Biotech | Portfolio page | ||
| Sampling Human builds production systems for generating cellular-resolution data from clinical samples | Healthcare & Biotech | Portfolio page | ||
| Sophomer s.r.o. is an academic startup that brings together immunoassays and polymer chemistry to help anyone who uses immunochemical assays in their work. | Healthcare & Biotech | Portfolio page | ||
| T-CURX is a biotechnology company that develops autologous CAR-T cell therapies for cancer treatment | Healthcare & Biotech | Dec 2025Series A | Page + round | |
| TernaryTx designs small molecule therapeutics using artificial intelligence and physics | Healthcare & Biotech | Mar 2026Seed | Page + round |
About this data
site last read 7 Nov 2026- Site
- inibio.eu
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 22 May 2024
- Companies checked
- 22
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get i&i Bio's profile as data
Pull i&i Bio's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/inibio.eu
# also
GET /v1/firms/inibio.eu/portfolio
GET /v1/firms/inibio.eu/coinvestors
GET /v1/firms/inibio.eu/news